April 25, 2017
Recommended Topic Related To:


"The US Food and Drug Administration (FDA) has cleared Omega3-rich fish skin for tissue healing for surgical applications, Kerecis, the Reykjavik, Iceland-based company that developed the product has announced.

Kerecis Omega3 SecureMes"...



(tedizolid phosphate) Tablets


SIVEXTRO (tedizolid phosphate), a phosphate prodrug, is converted to tedizolid in the presence of phosphatases.

Tedizolid phosphate has the chemical name [(5R)-(3-{3-Fluoro-4-[6-(2-methyl-2H-tetrazol- 5-yl) pyridin-3-yl]phenyl}-2- oxooxazolidin- 5-yl]methyl hydrogen phosphate.

Its empirical formula is C17H16FN6O6P and its molecular weight is 450.32. Its structural formula is:

SIVEXTRO (tedizolid phosphate) Structural Formula Illustration

Tedizolid phosphate is a white to yellow solid and is administered orally or by intravenous infusion.

The pharmacologically active moiety, tedizolid, is an antibacterial agent of the oxazolidinone class.

SIVEXTRO tablets contain 200 mg of tedizolid phosphate, and the following inactive ingredients: microcrystalline cellulose, mannitol, crospovidone, povidone, and magnesium stearate. In addition, the film coating contains the following inactive ingredients: polyvinyl alcohol, titanium dioxide, polyethylene glycol/macrogol, talc, and yellow iron oxide.

SIVEXTRO for injection is a sterile, white to off-white sterile lyophilized powder for injection in single-use vials of 200 mg. The inactive ingredients are mannitol (105 mg), sodium hydroxide, and hydrochloric acid, which is used in minimal quantities for pH adjustment.

Last reviewed on RxList: 11/21/2016
This monograph has been modified to include the generic and brand name in many instances.

Report Problems to the Food and Drug Administration


You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Women's Health

Find out what women really need.